David Estoppey
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Microbial Natural Products and Biosynthesis, Genomics and Phylogenetic Studies, RNA Interference and Gene Delivery, Bacterial Genetics and Biotechnology, Mosquito-borne diseases and control
Most-Cited Works
- → High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions(2013)182 cited
- → Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti‐Cancer Properties(2015)107 cited
- → The Natural Product Cavinafungin Selectively Interferes with Zika and Dengue Virus Replication by Inhibition of the Host Signal Peptidase(2017)79 cited
- → A reversible haploid mouse embryonic stem cell biobank resource for functional genomics(2017)77 cited
- → Decatransin, a novel natural product inhibiting protein translocation at the Sec61/SecY translocon(2015)69 cited
- → Identification of Elongation Factor G as the Conserved Cellular Target of Argyrin B(2012)51 cited
- → Identification and Evaluation of Novel Acetolactate Synthase Inhibitors as Antifungal Agents(2013)46 cited
- → Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells(2017)39 cited
- → IRF2 is a master regulator of human keratinocyte stem cell fate(2019)37 cited
- → Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol(2020)32 cited